The following pages link to RTK class III
External toolsShowing 50 items.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Chemotherapy (links | edit)
- Janus kinase (links | edit)
- Tyrosine kinase (links | edit)
- Metabotropic receptor (links | edit)
- Sirolimus (links | edit)
- Everolimus (links | edit)
- Imatinib (links | edit)
- Guanylate cyclase (links | edit)
- Insulin receptor (links | edit)
- Trastuzumab (links | edit)
- ATC code L (links | edit)
- ATC code L01 (links | edit)
- Gefitinib (links | edit)
- Rituximab (links | edit)
- Bevacizumab (links | edit)
- Cetuximab (links | edit)
- Epidermal growth factor receptor (links | edit)
- Soluble fms-like tyrosine kinase-1 (links | edit)
- ABL (gene) (links | edit)
- Erlotinib (links | edit)
- Ibritumomab tiuxetan (links | edit)
- Hepatocyte growth factor receptor (links | edit)
- Alemtuzumab (links | edit)
- Gemtuzumab ozogamicin (links | edit)
- HER2 (links | edit)
- Targeted therapy (links | edit)
- Sorafenib (links | edit)
- Tyrosin-protein kinase Lck (links | edit)
- Sunitinib (links | edit)
- MuSK protein (links | edit)
- Guanylate cyclase 2C (links | edit)
- Lapatinib (links | edit)
- ROR2 (links | edit)
- Tropomyosin receptor kinase A (links | edit)
- Tropomyosin receptor kinase B (links | edit)
- Tropomyosin receptor kinase C (links | edit)
- Insulin-like growth factor 1 receptor (links | edit)
- Receptor tyrosine kinase (links | edit)
- Ephrin receptor (links | edit)
- Platelet-derived growth factor receptor (links | edit)
- Fibroblast growth factor receptor (links | edit)
- Nilotinib (links | edit)
- Dasatinib (links | edit)
- Denileukin diftitox (links | edit)
- Tositumomab (links | edit)
- Bruton's tyrosine kinase (links | edit)
- Monoclonal antibody therapy (links | edit)
- Panitumumab (links | edit)
- ZAP70 (links | edit)
- Vandetanib (links | edit)